ClinicalTrials.gg
RecruitingNCT07798557Updated Sep 1, 2026

BRIDGE & Friends Trial

An interventional study of Social Network Curriculum in Obesity & Overweight, sponsored by University of Illinois at Chicago. Recruiting at 1 site in United States. Open to participants aged 50 Years to 79 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-01.

Sponsored by University of Illinois at Chicago · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Feb 2026, registered Aug 2026).
  • Started Feb 2026; still recruiting 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
532
Allocation
Randomized
Ages
50 Years to 79 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 35 studies in Obesity by University of Illinois at Chicago — 6 open to participants now, 8 under way, none of them phase 3. Obesity · University of Illinois at Chicago.

Planned enrollment
4th of 33
532 · median 90
Started
2026
with 1 other
No phase
29 of 35
5 open now
Registered
35th of 35
by date

Among the 35 studies in Obesity by University of Illinois at Chicago, this one is the 4th largest by planned enrollment of the 33 interventional ones that give a count, is one of 2 that started in 2026, is one of 29 with no phase, and was the 35th registered.

Obesity

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

Browse Obesity studies →

Open to participants now

6 of the 35 studies in Obesity by University of Illinois at Chicago are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 6 open studies →

Where they have run

Who these studies take

Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.

This study: 50 Years to 79 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 35 studies in Obesity by University of Illinois at Chicago, or all of them as a file.
02

Study summary

Aim 1. Conduct a 6-month (24-session) RCT comparing MedDiet-WL to MedDiet-SN among 268 older adults with obesity (50-79 years, BMI = 30-50 kg/m²). We hypothesize that 1) Participants in MedDiet-SN will show improvements in bodyweight/BMI and body fat compared to MedDiet-WL at post-intervention (6-months), 2) Participants in MedDiet-SN will show improvements in diet (diet quality) and physical activity (step counts) compared to MedDiet-WL at post-intervention (6-months), and 3) Participants in MedDiet-SN will maintain these improvements at 12-months.

Aim 2. Characterize and compare differences in weight management information dissemination by 268 randomized to MedDiet-WL and MedDiet-SN. We hypothesize that MedDiet-SN participants will share information to more network members compared to participants in MedDiet-WL.

Aim 3. Compare MedDiet-SN and MedDiet-WL in 268 network members. We hypothesize that MedDiet-SN network members will show, greater improvements in BMI, body fat, diet, and physical activity than MedDiet-WL network members at 6 months. We will explore how effects may vary by network (e.g., density, relationships), and messaging characteristics (e.g., modality).

03

Conditions studied

  • Obesity & Overweight
04

Who can participate

Ages eligible
50 Years to 79 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 50-79 yrs old,
  • 30-50
  • Willing to participate in all procedures
  • Understand English
  • Willing to make changes to diet and lifestyle
  • Have access to a phone
  • Plan to reside in the Chicago area for the next 12 months

Exclusion criteria

Exclusion Criteria:

  • Severe ischemic heart disease
  • Severe pulmonary disease
  • Bariatric surgery
  • Cancer treatment within the past 12 months
  • Current adherence to MedDiet based on dietary screening
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
532 participants (estimated)

Study arms

  • Active comparator
    MD-WL

    Mediterranean Diet Weight Loss

    Behavioral: Social Network Curriculum

  • Active comparator
    MD-WL SN

    Mediterranean Diet Weight Loss Social Networks

    Behavioral: Social Network Curriculum

Interventions

  • BehavioralSocial Network Curriculum

    Empowerment to share lifestyle change information within social networks

    Also known as: MD-WL SN

06

What researchers measure

Primary outcomes

  1. Physical Activity

    Godin-Shephard Leisure Time Physical Activity Questionnaire

    Time frame: 6 months

  2. Anthropometrics, Body Fat

    BMI, body fat measure by stadiometer and scale

    Time frame: 6 months

  3. Dietary Intake

    Vioscreen Food Frequency Questionnaire

    Time frame: 6 months

  4. Mediterranean Diet adherence

    Mediterranean Eating Patterns for Americans (MEPA) is a 16-item screener that assesses adherence to a MedDiet pattern

    Time frame: 6 months

Secondary outcomes

  1. Community Network Factors

    General Social Survey Instrument, including support network size, characteristics, health information dissemination

    Time frame: 6 months

Other outcomes

  1. Additional Measures for Co-Variates, Mediators and Moderators

    Leadership \& self efficacy. Promise- Quality of Life Questionnaire, Social Support, Intrinsic Motivation, Depression,

    Time frame: 6 month

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2026 (actual). Primary completion is estimated for Jun 2029, 40 months after the start.

Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 40 months is above that.

Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 25, 2026
First posted
Sep 1, 2026
StartActual
Feb 1, 2026
Primary completionEst.
Jun 30, 2029
CompletionEst.
Dec 31, 2029
Last update
Sep 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07798557
Responsible party
Lara Blumstein (Professor, University of Illinois at Chicago) — Principal investigator
First posted
Sep 1, 2026
Start date
Feb 1, 2026
Primary completion
Jun 30, 2029 (estimated)
Completion
Dec 31, 2029 (estimated)
Last update
Sep 1, 2026

Study contacts

Lara Blumstein, MA
Contact
lbb@uic.edu
+1 77304903311
Marian Fitzgibbon, PhD
Contact
lbb@uic.edu
+1 77304903311

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion